Warning letter
Montana Compounding Pharmacy: warning letter of Dec 11, 2015
FDA warning letter 477564 · Seattle District Office
Key facts
| Reference number | 477564 |
|---|---|
| Company | Montana Compounding Pharmacy |
| Subject | Compounding Pharmacy/Adulteration/Misbranding |
| Issue date | Dec 11, 2015 |
| Posted date | Jan 19, 2016 |
| Issuing office | Seattle District Office |
| Product type | Drugs |
| CFR sections cited | 201.115, 211, 211.111, 211.28(a), 211.42(c)(10)(iv), 211.42(c)(10)(v), 211.56(a), 211.84(d)(2), 211.84(d)(6), 211.113(b), 211.167(a) |
| Inspection city | Missoula |
| Inspection ZIP | 59802 |
| Inspection start date | Apr 28, 2015 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: